Item 5. Other Information
Item 5. Other Information
Rule 10b5-1 trading arrangements
During the Company’s second
quarter of 2025, no director or officer adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading
arrangement.
18
Item 6. Exhibits
The following is a complete list of exhibits filed
as part of this Form 10-Q. Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K.
EXHIBIT INDEX
The following documents are being filed with the Commission
as exhibits to this Quarterly Report on Form 10-Q.
Incorporated by Reference
Filed or
Furnished
No.
Exhibit Description
Form
Date Filed
Number
Herewith
3.1
Amended and Restated Articles of Incorporation as filed on February 16, 2022
8-K
2/14/2022
3.1
3.2
Amended and Restated Bylaws of the Company as approved on December 20, 2021
8-K
12/23/2021
3.2
4.1
Amended 2017 Stock Option and Stock Bonus Plan
8-K
11/13/2018
4.1
4.2
Amendment to Amended 2017 Stock Option and Stock Bonus Plan as approved on July 15, 2019
8-K
7/17/2019
4.1
4.3
Amendment to Amended 2017 Stock Option and Stock Bonus Plan as approved on April 6, 2020
8-K
4/10/2020
4.1
4.4
Consultant Warrant
10-K
3/17/2023
4.4
4.5
Form of
Warrant
10-Q
5/15/2025
4.5
10.1
Royalty Agreement between the Company and The Governors of the University of Alberta, dated April 8, 2015
10-K
4/14/2015
10.6
10.2
Collaborative Research Agreement between the Company and the University of British Columbia, dated May 31, 2016
10-Q
8/15/2016
10.10
10.3
Consulting Agreement between the Company and Clarence E. Smith, dated December 30, 2016
10-K
2/21/2017
10.9
10.4
Director Consulting Agreement between the Company and Edward P. McDonough, dated December 30, 2016
10-K
2/21/2017
10.11
10.5
Consulting Agreement between the Company and Grant Young, dated December 30, 2016
10-Q
11/13/2017
10.13
10.6
First Amendment to Consulting Agreement between Clarence E. Smith and the Company dated September 1, 2017
8-K/A
9/12/2017
10.1
10.7
First Amendment to Consulting Agreement between Grant Young and the Company dated September 1, 2017
8-K/A
9/12/2017
10.3
10.8
First Amendment to Consulting Agreement between Edward P. McDonough and the Company dated September 1, 2017
8-K/A
9/12/2017
10.2
10.9
Consulting Agreement between ProtoKinetix Incorporated and Michael Guzzetta, dated November 14, 2017
8-K
11/15/2017
10.1
31.1
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Filed
31.2
Certification of the Principal Financial Officer and Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Filed
32.1
Certification of the Principal Executive Officer and the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Furnished, not filed herewith
101.INS
XBRL Instance Document
Filed
101.SCH
XBRL Schema Document
Filed
101.CAL
XBRL Calculation Linkbase Document
Filed
101.DEF
XBRL Definition Linkbase Document
Filed
101.LAB
XBRL Label Linkbase Document
Filed
101.PRE
XBRL Presentation Linkbase Document
Filed
104
Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
Filed
19
SIGNATURES
Pursuant to the requirements of Section 12 of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Date: August 13, 2025
PROTOKINETIX, INCORPORATED
By: /s/ Clarence E. Smith
Clarence E. Smith
Chief Executive Officer
By: /s/ Michael R. Guzzetta
Michael R. Guzzetta
Chief Financial Officer
20
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.